ICARISIDE-II
Compound with spectra: 3 NMR
| SpectraBase Compound ID | HrtWKTK0eDG |
|---|---|
| InChI | InChI=1S/C27H30O10/c1-12(2)5-10-16-17(28)11-18(29)19-21(31)26(37-27-23(33)22(32)20(30)13(3)35-27)24(36-25(16)19)14-6-8-15(34-4)9-7-14/h5-9,11,13,20,22-23,27-30,32-33H,10H2,1-4H3/t13-,20-,22+,23+,27-/m0/s1 |
| InChIKey | NGMYNFJANBHLKA-LVKFHIPRSA-N |
| Mol Weight | 514.53 g/mol |
| Molecular Formula | C27H30O10 |
| Exact Mass | 514.183897 g/mol |
| Enantiomer InChIKey | NGMYNFJANBHLKA-VOVROMDUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
- ISCARDIDE_II
- BAOHUOSIDE-I;8-PRENYL-KAEMPFEROL-4'-METHYLETHER-3-O-RHAMNOPYRANOSIDE
RPLMLWBOUPDPQF-ZZPWHPGWSA-N
BAOHUOSIDE-II;8-PRENYL-KAEMPFEROL-3-O-RHAMNOPYRANOSIDE
Ikarisoside A
8-METHOXY-KAEMPFEROL-3-O-BETA-D-GLUCOSIDE
GOSSYPETIN-3-O-BETA-GALACTOPYRANOSIDE;LJ-YP-1
GOSSYPETIN-3-O-BETA-GLUCOPYRANOSIDE;LJ-YP-2
QUERCETIN-3,4'-DI-O-BETA-D-GLUCOPYRANOSIDE
6-METHOXY-KAEMPFEROL-3-O-BETA-D-6''-(PARA-COUMAROYL)-GLUCOPYRANOSIDE
CYPELLOGIN-A
CYPELLOGIN-B
| Title | Journal or Book | Year |
|---|---|---|
| Preparation of icariside II from icariin by enzymatic hydrolysis method | Fitoterapia | 2010 |
| Anhydroicaritin 3-O-rhamnosyl(1 → 2)rhamnoside from Epimedium koreanum and a reappraisal of other rhamnosyl(1 → 2, 1 → 3 and 1 → 4)rhamnoside structures | Phytochemistry | 1996 |
| Flavonol glycosides fromEpimedium wushanense | Phytochemistry | 1990 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.